Clinical Trials Directory

Trials / Completed

CompletedNCT03767816

The Visceral Analgesic Effect of Erector Spinae Plane Block in Laparoscopic Cholecystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to investigate the effectiveness of erector spinae plane block on postoperative visceral pain in laparoscopic cholecystectomy (LLC). Given that rectus sheath block may provide sufficient somatic pain block, investigators aimed to investigate whether erector spinae block is effective in visceral pain block. After induction of general anesthesia, group of patient is decided randomly. In Group R, rectus sheath block is performed with 0.2% Ropivacaine 30ml before the operation. In Group RE, rectus sheath block and erector spinae plane block are performed with 0.2% ropivacaine 70ml before the operation. NRS score measurement and comparison of the rescue analgesic dose used at 0, 0.5, 1, 2,6, 12, 18, and 24 hours after arrival at the recovery room were collected

Conditions

Interventions

TypeNameDescription
DRUGUltrasound guided Rectus sheath blockUltrasound guided rectus sheath block with 0.2% ropivacaine (Fresenius Kabi) 30ml around umbilicus
DRUGUltrasound erector spinae plane blockUltrasound guided erector spinae plane block with 0.2% ropivacaine (Fresenius Kabi) 40ml at T7 level

Timeline

Start date
2018-12-17
Primary completion
2019-03-30
Completion
2019-06-30
First posted
2018-12-07
Last updated
2019-07-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03767816. Inclusion in this directory is not an endorsement.